Hazards of gallamine administration in patients with renal failure.
D000759:Adjuvants, Anesthesia / Q000009:adverse effects*; D000328:Adult; D000769:Anesthesia, Inhalation; D001806:Blood Urea Nitrogen; D004381:Duodenal Ulcer / Q000601:surgery; D005260:Female; D005703:Gallamine Triethiodide / Q000009:adverse effects*; D006221:Halothane; D006801:Humans; D007044:Hysterectomy; D007674:Kidney Diseases / Q000601:surgery*; D007676:Kidney Failure, Chronic / Q000150:complications*; D008297:Male; D008875:Middle Aged; D009388:Neostigmine / Q000627:therapeutic use; D009392:Nephrectomy; D009609:Nitrous Oxide; D010243:Paralysis / Q000139:chemically induced*; D011188:Potassium / Q000097:blood; D006435:Renal Dialysis; D012133:Respiratory Paralysis / Q000139:chemically induced*
D000759:Adjuvants, Anesthesia; D009388:Neostigmine; D009609:Nitrous Oxide; D005703:Gallamine Triethiodide; D011188:Potassium; D006221:Halothane